Personal information

Other IDs

Loop profile: 790722

Activities

Collapse all

Works (26)

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer

Journal for ImmunoTherapy of Cancer
2025-03 | Journal article
DOI: 10.1136/jitc-2024-010959
Contributors: Oladapo O Yeku; Minal Barve; Winston W Tan; Judy Wang; Amita Patnaik; Patricia LoRusso; Debra L Richardson; Abdul Rafeh Naqash; Sarah K Lynam; Siqing Fu et al.
Source: check_circle
Crossref

NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors

New England Journal of Medicine
2025-02-13 | Journal article
DOI: 10.1056/NEJMe2411486
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine
2025-01-02 | Journal article
DOI: 10.1056/NEJMe2411485
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

New England Journal of Medicine
2025-01-02 | Journal article
DOI: 10.1056/NEJMe2411489
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Ponsegromab in Cancer Cachexia

New England Journal of Medicine
2024-12-19 | Journal article
DOI: 10.1056/NEJMe2411491
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

New England Journal of Medicine
2024-12-05 | Journal article
DOI: 10.1056/NEJMe2411488
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer

New England Journal of Medicine
2024-11-28 | Journal article
DOI: 10.1056/NEJMe2411492
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

New England Journal of Medicine
2024-11-14 | Journal article
DOI: 10.1056/NEJMe2411490
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer

New England Journal of Medicine
2024-11-14 | Journal article
DOI: 10.1056/NEJMe2411487
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer

New England Journal of Medicine
2024-10-10 | Journal article
DOI: 10.1056/NEJMe2411493
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

New England Journal of Medicine
2024-09-26 | Journal article
DOI: 10.1056/NEJMe2411494
Contributors: Eric J. Rubin; Oladapo O. Yeku; Stephen Morrissey
Source: check_circle
Crossref

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial

JCO Precision Oncology
2024-05 | Journal article
DOI: 10.1200/PO.23.00693
Contributors: Joyce F. Liu; Stéphanie Gaillard; Andrea E. Wahner Hendrickson; Oladapo Yeku; Elisabeth Diver; Camille Gunderson Jackson; Rebecca Arend; Elena Ratner; Vivek Samnotra; Divya Gupta et al.
Source: check_circle
Crossref

Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.c.7209110
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.c.7209110.v1
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Clinical Cancer Research
2024-05-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-3135
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Supplementary Material 1 from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.25728644.v1
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Supplementary Material 1 from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

2024-05-01 | Preprint
DOI: 10.1158/1078-0432.25728644
Contributors: Ryan B. Corcoran; Khanh T. Do; Jeong E. Kim; James M. Cleary; Aparna R. Parikh; Oladapo O. Yeku; Niya Xiong; Colin D. Weekes; Jennifer Veneris; Leanne G. Ahronian et al.
Source: check_circle
Crossref

Racial disparities and referral for genetic counseling

Cancer
2024-02-15 | Journal article
DOI: 10.1002/cncr.35062
Contributors: Oladapo O. Yeku
Source: check_circle
Crossref

Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

JCO Precision Oncology
2023-09 | Journal article
DOI: 10.1200/PO.23.00235
Contributors: Linda R. Duska; Dmitriy Zamarin; Erica Hamilton; Amit Oza; Gini Fleming; Alexander Spira; Oladapo O. Yeku; Debra L. Richardson; Jackie Walling; Kerry Inokuchi et al.
Source: check_circle
Crossref

Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer

New England Journal of Medicine
2023-05-04 | Journal article
DOI: 10.1056/NEJMe2300385
Contributors: Oladapo O. Yeku; Dan L. Longo
Source: check_circle
Crossref

CAR T Cells for Neuroblastoma

New England Journal of Medicine
2023-04-06 | Journal article
DOI: 10.1056/NEJMe2300317
Contributors: Oladapo O. Yeku; Dan L. Longo
Source: check_circle
Crossref

Three Cases of Atypical Cutaneous Ovarian Metastases: A Single-Center Case Series

Annals of Internal Medicine: Clinical Cases
2022-11-01 | Journal article
DOI: 10.7326/aimcc.2022.0541
Contributors: Azucena Ramos; Erin Theisen; Lyn M. Duncan; Jennifer Filipi; Yun Kao; Oladapo O. Yeku
Source: check_circle
Crossref

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

Journal of Translational Medicine
2020-12 | Journal article
DOI: 10.1186/s12967-020-02523-5
Contributors: Oladapo Yeku; Andrea L. Russo; Hang Lee; David Spriggs
Source: check_circle
Crossref

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

2020-09-03 | Preprint
DOI: 10.21203/rs.3.rs-37030/v2
Contributors: Oladapo Yeku; Andrea L Russo; Hang Lee; David Spriggs
Source: check_circle
Crossref

PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature

Case Reports in Oncological Medicine
2020-08-31 | Journal article
DOI: 10.1155/2020/3428945
Contributors: Amanda Ramos; Marcela del Carmen; Oladapo Yeku
Source: check_circle
Crossref

A Phase 2 Study of Combined Chemo-Immunotherapy with Cisplatin-Pembrolizumab and Radiation for Unresectable Vulvar Squamous Cell Carcinoma

2020-06-29 | Preprint
DOI: 10.21203/rs.3.rs-37030/v1
Contributors: Oladapo Yeku; Andrea L Russo; Hang Lee; David Spriggs
Source: check_circle
Crossref

Peer review (6 reviews for 2 publications/grants)

Review activity for British journal of cancer. (2)
Review activity for Journal for immunotherapy of cancer. (4)
How many people are using ORCID?